Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
86.77
-0.89 (-1.02%)
Jun 3, 2026, 10:00 AM EDT - Market open

Company Description

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally.

It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands.

The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve.

It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Edwards Lifesciences Corporation
Edwards Lifesciences logo
CountryUnited States
Founded1958
IPO DateMar 27, 2000
IndustryMedical Devices
SectorHealthcare
Employees16,000
CEOBernard Zovighian

Contact Details

Address:
One Edwards Way
Irvine, California 92614
United States
Phone949 250 2500
Websiteedwards.com

Stock Details

Ticker SymbolEW
ExchangeNYSE
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001099800
CUSIP Number28176E108
ISIN NumberUS28176E1082
Employer ID36-4316614
SIC Code3842

Key Executives

NamePosition
Bernard J. ZovighianChief Executive Officer and Director
Joseph NuzzoleseCorporate Vice President of Global Operations and Quality
Andrew M. DahlPrincipal Accounting Officer, Senior Vice President and Corporate Controller
Dr. Todd Brinton FACC, M.D.Corporate Vice President of Advanced Innovation and Technology and Chief Scientific Officer
Snehashish SarkarSenior Vice President and Chief Information and Digital Officer
Mark D. PetersonCorporate Vice President and General Counsel
Dirksen J. LehmanCorporate Vice President of Public Affairs
Christine Z. McCauleyCorporate Vice President of Human Resources
Gary I. SorsherSenior Vice President of Quality and Regulatory Compliance
Wayne T. MarkowitzGM and Senior Vice President of Surgical Structural Heart

Latest SEC Filings

DateTypeTitle
May 29, 2026144Filing
May 29, 2026144Filing
May 27, 2026SDForm - SD
May 27, 2026144Filing
May 22, 2026144Filing
May 18, 2026144Filing
May 15, 2026144Filing
May 12, 2026144Filing
May 11, 2026144Filing
May 8, 20268-KCurrent Report